McKay, Kyla A.
Wickström, Ronny
Hillert, Jan
Karrenbauer, Virginija Danylaite
Funding for this research was provided by:
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2019-00190)
Karolinska Institute
Article History
Received: 22 April 2021
Accepted: 26 August 2021
First Online: 17 September 2021
Competing interests
: KAM receives postdoctoral research support from the CIHR and the Swedish Research Council for Health, Working life and Welfare. RW has received honoraria for serving on advisory boards for Octapharma, Roche and Novartis. He has served as P.I. for a project from Biogen and received financial support from Stockholm City Council. JH has received honoraria for serving on advisory boards for Biogen, Merck, Novartis, Sandoz, Sanofi-Genzyme and Celgene and speaker’s fees from Biogen, Novartis, Merck and Sanofi-Genzyme. He has served as P.I. for projects, or received unrestricted research support from, Celgene, Biogen, Merck, Novartis, Roche and Sanofi-Genzyme. VDK has received financial support from Stockholm County Council (Grant recipient ALF 20160457); Biogen (recipient of grant and scholarship, PI for project sponsored by); Novartis (recipient of scholarship and lecture honoraria); Merck (Scientific Advisory Board member, recipient of lecture honoraria).